Rhodiola Rosea Ireland: Benefits, Dosage & Evidence Guide
Rhodiola rosea is an adaptogenic herb used in traditional medicine across Russia, Scandinavia, and Central Asia for centuries. Interest in it has grown steadily in Ireland, driven by searches for natural support with stress, fatigue, and mood. This guide covers what the clinical evidence actually shows — and what it does not.
Rhodiola rosea is a food supplement root extract used traditionally to support the body's response to stress and fatigue. The most studied active compounds are rosavins and salidroside. Published RCTs, including Olsson et al. (Phytomedicine, 2009), have reported reductions in burnout-related fatigue after 28 days of supplementation with standardised extract SHR-5. Typical studied doses range from 200–600 mg per day of standardised extract. Rhodiola rosea is not a medicine and does not treat any medical condition. In Ireland, it is classified as a food supplement regulated under FSAI guidelines.
- What Is Rhodiola Rosea?
- Active Compounds: Rosavins and Salidroside
- How Rhodiola Rosea Works
- Rhodiola Rosea Benefits: What the Evidence Shows
- Rhodiola Rosea for Stress and Anxiety
- Rhodiola Rosea and Mood
- Dosage and How Long to Take It
- Side Effects and Safety
- Rhodiola Rosea vs Ashwagandha
- Where to Buy Rhodiola Rosea in Ireland
- Frequently Asked Questions
What Is Rhodiola Rosea?
Rhodiola rosea — also known as golden root, Arctic root, or roseroot — is a perennial flowering plant in the Crassulaceae family. It grows naturally in cold mountain regions: the Arctic, Siberia, Scandinavia, and parts of Central Asia. The root has been used in traditional herbalism across these regions for hundreds of years.[1]
In traditional Russian and Scandinavian medicine, Rhodiola rosea root was used to support endurance, reduce fatigue, and help the body adapt to harsh environmental conditions. Soviet-era researchers conducted significant early work on it as part of a broader investigation into adaptogens — plants thought to help the body adapt to physical and psychological stressors without causing overstimulation.[1]
In modern use, Rhodiola rosea is sold as a food supplement in Ireland. It is classified as a traditional herbal product and falls under FSAI food supplement guidelines. It is not a medicine and is not authorised to treat, cure, or prevent any disease.
In Ireland, Rhodiola rosea is sold as a food supplement, not a medicinal product. It is regulated by the Food Safety Authority of Ireland (FSAI). No authorised health claims under EC Regulation 1924/2006 currently apply to Rhodiola rosea. If you are experiencing persistent fatigue, low mood, or anxiety, consult your GP.
Active Compounds: Rosavins and Salidroside
Not all Rhodiola supplements are equal. The quality of a Rhodiola rosea product depends significantly on which compounds it contains and whether they are standardised.
Rosavins — rosavin, rosarin, and rosin — are cinnamyl alcohol glycosides found almost exclusively in Rhodiola rosea. They are the primary marker used to distinguish genuine Rhodiola rosea from other Rhodiola species. Research-backed extracts are typically standardised to 3% rosavins. The SHR-5 extract used in multiple published clinical trials is standardised to both 3% rosavins and 1% salidroside.[2]
Salidroside (also called tyrosol glucoside or rhodioloside) is present across several Rhodiola species and is considered a significant contributor to the plant's adaptogenic properties. It is well-studied for its effects on stress response pathways and is thought to influence monoamine neurotransmitters including serotonin, dopamine, and norepinephrine.[1]
Swanson Rhodiola Rosea Root 400 mg provides 400 mg of whole-root powder per capsule. This is a full-spectrum root product. It is different from a standardised extract, which concentrates specific active compounds to a defined percentage. Both formats are commercially available in Ireland.
When buying Rhodiola rosea in Ireland, check whether the product is a whole-root powder or a standardised extract. Standardised extracts specify the percentage of rosavins and salidroside. Research trials have typically used standardised extracts (e.g., SHR-5 at 3% rosavins / 1% salidroside). Whole-root products contain the full spectrum of plant compounds at natural concentrations.
How Rhodiola Rosea Works
Rhodiola rosea is classified as an adaptogen — a substance proposed to support the body's non-specific resistance to stressors. The precise mechanisms are not fully established, but current research points to several interconnected pathways.[1]
Rhodiola rosea is proposed to modulate the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress response system. Salidroside in particular is thought to influence cortisol secretion patterns during acute stress exposure.
Active compounds in Rhodiola rosea root are proposed to support levels of serotonin, dopamine, and norepinephrine in the brain — neurotransmitters involved in mood regulation, motivation, and cognitive function.
Salidroside has been studied for effects on mitochondrial function and ATP production. Some research suggests it may support energy metabolism at the cellular level, which could relate to the fatigue-reducing effects observed in RCTs.
Both rosavins and salidroside have antioxidant properties in laboratory studies. Chronic stress is associated with elevated oxidative stress markers; Rhodiola rosea compounds may help moderate this response, though human data is limited.
Preliminary research suggests Rhodiola rosea may help regulate the cortisol stress response without fully suppressing it. Unlike some calming compounds, it does not appear to be sedating — which may explain its use for daytime fatigue.
Some studies have investigated Rhodiola rosea in the context of exercise-related fatigue. Proposed mechanisms include effects on oxygen utilisation and lactate clearance, though human evidence in this area remains mixed.
Important note: the mechanistic research on Rhodiola rosea is largely preclinical — conducted in cell models or animal studies. Human clinical data exists primarily for fatigue and mood outcomes, not for the mechanistic pathways above. Mechanisms described here are proposed pathways, not proven clinical effects.
Rhodiola Rosea Benefits: What the Evidence Shows
The evidence base for Rhodiola rosea is more developed than many herbal supplements, but it is not without limitations. Most published RCTs are small to medium in size (30–160 participants), and several have been conducted by researchers with close ties to the SHR-5 extract developers. A balanced reading of the literature is essential.
A randomised, double-blind, placebo-controlled trial by Olsson EM, von Schéele B, and Panossian AG enrolled 60 adults with burnout diagnosis. Participants received standardised Rhodiola rosea extract SHR-5 or placebo for 28 days. The SHR-5 group showed statistically significant improvements in the Pines Burnout Scale (p<0.05), attention and cognitive function tests, and self-reported mental fatigue. No serious adverse events were reported.
Olsson EM et al. Planta Medica. 2009;75(2):105-112. — PubMed 19016404[3]
A double-blind, crossover study by Darbinyan V, Kteyan A, and Panossian A tested the SHR-5 extract in 56 young physicians during a 2-week night-duty period. The Rhodiola group showed significant improvements in a fatigue index (p<0.01) and performance tests including arithmetic, short-term memory, and concentration speed. The effect was observed at a relatively low single dose (170 mg/day of extract). This is one of the more cited studies for acute performance effects.
Darbinyan V et al. Phytomedicine. 2000;7(5):365-371. — PubMed 11081987[4]
An open-label clinical trial by Lekomtseva Y, Zhukova I, and Wacker A assessed Rhodiola rosea extract (WS 1375, 200 mg twice daily) over 8 weeks in 100 adults with prolonged or chronic fatigue. Fatigue scores on the MFI-20 scale improved significantly from week 1 onward (p<0.001), with continued improvement through week 8. Limitations include the open-label design and absence of a placebo control group — results should be interpreted accordingly.
Lekomtseva Y et al. Complementary Medicine Research. 2017;24(1):46-52. — PubMed 28219059[5]
An important comparative trial by Mao JJ, Xie SX, and Zee J (University of Pennsylvania) compared Rhodiola rosea extract, sertraline (an SSRI antidepressant), and placebo in 57 adults with mild-to-moderate major depressive disorder over 12 weeks. Neither Rhodiola nor sertraline significantly outperformed placebo on the primary outcome (HAMD-17 scores). Sertraline produced greater clinical response but also more side effects. Rhodiola showed a more favourable side-effect profile. This trial is frequently misrepresented — it did not establish that Rhodiola treats depression, and the small sample size limits conclusions.
Mao JJ et al. Phytomedicine. 2015;22(3):394-399. — PubMed 25837277[6]
Most Rhodiola rosea RCTs are small in sample size (under 100 participants) and relatively short in duration. Several key studies were conducted by researchers connected to the SHR-5 extract developers. Independent replication in larger trials is limited. Results should not be extrapolated to all Rhodiola products — extract type, standardisation, and dose all matter. These are food supplement findings, not medical claims.
Swanson Rhodiola Rosea Root 400 mg
Full-spectrum Rhodiola rosea root powder · 100 capsules · Available in Ireland from Probiotic.ie
Rhodiola Rosea for Stress and Anxiety
The most robust clinical evidence for Rhodiola rosea relates to stress and stress-induced fatigue. Multiple RCTs and observational studies have examined its effects in people experiencing burnout, high-demand work schedules, or acute stress exposure.
A 2015 study by Cropley M, Banks AP, and Boyle J (University of Surrey) investigated the effects of Rhodiola rosea extract on 80 mildly anxious adults over 14 days. Participants receiving the extract showed significant reductions in perceived stress, anxiety, anger, confusion, and depression scores compared with baseline (p<0.05).[7] This was not a placebo-controlled trial — all participants received the active product — so placebo effects cannot be ruled out.
A 2003 RCT by Shevtsov VA et al. tested two doses of SHR-5 extract (170 mg and 555 mg) versus placebo in 161 military cadets performing demanding cognitive tasks under sleep deprivation and stress. Both active doses significantly improved performance on an anti-fatigue index compared to placebo (p<0.01), with no significant difference between doses.[2]
Rhodiola rosea is often described as non-sedating — a distinction from anxiolytic compounds like L-theanine or valerian. Its proposed stimulating-yet-calming character makes it more commonly used for stress during high-demand periods rather than for relaxation or sleep support.
Rhodiola rosea is a food supplement and is not a treatment for anxiety disorders, generalised anxiety disorder (GAD), panic disorder, or any other diagnosed mental health condition. If you experience persistent or severe anxiety, consult your GP or a mental health professional. The HSE provides support for anxiety through your local GP or through the Samaritans (116 123, free, 24/7).
Rhodiola Rosea and Mood
Several studies have examined Rhodiola rosea in the context of low mood and depression. The evidence is suggestive but not conclusive — and it is important to present the conflicting findings honestly.
The Mao et al. (2015) comparative trial, discussed above under evidence cards, found that Rhodiola rosea did not significantly outperform placebo for major depressive disorder. However, the trial was likely underpowered for the magnitude of effect being sought. The study authors concluded that Rhodiola rosea showed a "clinically meaningful but statistically non-significant" effect, with a considerably better tolerability profile than sertraline.[6]
A 2018 systematic review by Anghelescu IG, Edwards D, Seifritz E, and Kasper S in the International Journal of Psychiatry in Clinical Practice concluded that Rhodiola rosea showed consistent effects on stress symptoms, fatigue, and depressive mood in non-clinical and mildly symptomatic populations, but noted that evidence in clinical depression remains insufficient to draw firm conclusions.[1]
The proposed mechanism for mood effects involves modulation of serotonin and dopamine pathways via inhibition of monoamine oxidase (MAO-A and MAO-B enzymes), which are also the target of certain antidepressant medications. This is the basis for caution around combining Rhodiola rosea with prescribed antidepressants — see the Safety section.
Rhodiola rosea is not a treatment for clinical depression. If you are experiencing persistent low mood, loss of interest, or other symptoms of depression, consult your GP. Effective treatments for depression are available through the HSE. Do not substitute or discontinue prescribed antidepressant medication without medical advice.
Rhodiola Rosea Dosage and How Long to Take It
There is no single universally agreed dose for Rhodiola rosea supplementation. Doses used in published clinical trials vary based on extract type, standardisation level, and study design.
| Study | Extract / Form | Daily Dose | Duration | Outcome |
|---|---|---|---|---|
| Olsson et al. 2009 | SHR-5 (3% rosavins / 1% salidroside) | 576 mg extract | 28 days | Fatigue ↓ (p<0.05) |
| Darbinyan et al. 2000 | SHR-5 (standardised extract) | 170 mg extract | 14 days | Mental performance ↑ (p<0.01) |
| Shevtsov et al. 2003 | SHR-5 | 170 mg or 555 mg | Single dose | Anti-fatigue index ↑ (p<0.01) |
| Lekomtseva et al. 2017 | WS 1375 (200 mg twice daily) | 400 mg extract | 8 weeks | Fatigue (MFI-20) ↓ (p<0.001) |
| Mao et al. 2015 | Not specified (standardised) | 340 mg extract | 12 weeks | Non-significant vs placebo (MDD) |
| Cropley et al. 2015 | Rhodiola rosea extract | 400 mg extract | 14 days | Stress & anxiety scores ↓ (p<0.05) |
Swanson Rhodiola Rosea Root 400 mg provides whole-root powder at 400 mg per capsule. Suggested use as a food supplement: one capsule once to twice per day with water. This is a whole-root product, not a concentrated extract — so the dose is not directly comparable to the standardised extract doses used in RCTs.
When to Take Rhodiola Rosea
Most practitioners and trial protocols suggest taking Rhodiola rosea in the morning or early afternoon. Its mildly stimulating properties mean it can interfere with sleep if taken late in the day. Take with a glass of water, with or without food.
How Long to Take It
Rhodiola Rosea Side Effects and Safety
Rhodiola rosea has a generally good tolerability profile in published trials. Reported adverse events in RCTs have been mild and transient. However, certain groups should exercise caution or avoid it entirely.
| Population | Guidance |
|---|---|
| Healthy adults | Generally well tolerated at studied doses. Mild side effects reported: dizziness, dry mouth, agitation. |
| Pregnant or breastfeeding | Do not use. No safety data in pregnancy. Manufacturer and FSAI guidance: not suitable. |
| Taking antidepressants (SSRIs, SNRIs, MAOIs) | Consult GP before use. Potential serotonergic interaction. Do not combine without medical supervision. |
| Taking blood pressure medication | Consult GP. Some evidence that Rhodiola rosea may affect blood pressure. Interaction data is limited. |
| Diagnosed anxiety disorder | Consult GP. Some individuals report increased agitation at higher doses. Not a treatment for anxiety disorders. |
| Autoimmune conditions | Consult GP. Adaptogenic herbs may theoretically influence immune function. Evidence in this population is absent. |
| Under 18 years | Not intended for use by individuals under 18 years of age. |
Rhodiola rosea compounds are proposed to influence monoamine pathways (serotonin, dopamine, norepinephrine). Combining Rhodiola rosea with antidepressant medications — particularly SSRIs, SNRIs, tricyclics, or MAO inhibitors — carries a theoretical risk of serotonin syndrome. This is not a documented case series finding, but a pharmacological caution. Do not combine Rhodiola rosea with prescription psychiatric medication without consulting your prescribing GP or psychiatrist. Inform your pharmacist that you are taking Rhodiola rosea if you are on any regular medication.
Rhodiola Rosea vs Ashwagandha: Which Should You Choose?
Both Rhodiola rosea and ashwagandha (Withania somnifera) are classified as adaptogens and are frequently compared. They have distinct profiles, different evidence bases, and are suited to different use cases.
| Factor | Rhodiola Rosea | Ashwagandha (KSM-66 / Sensoril) |
|---|---|---|
| Primary origin | Arctic, Siberia, Scandinavia | India, Ayurvedic medicine |
| Character / effect profile | More stimulating / energising | More calming / sedating |
| Best studied for | Stress-related fatigue, acute mental performance | Chronic stress, cortisol reduction, sleep quality |
| Sleep support | Not recommended before bed | Studied for sleep quality improvement |
| Active compounds | Rosavins, salidroside | Withanolides, withaferin A |
| Key RCT evidence | Olsson 2009, Darbinyan 2000, Shevtsov 2003 | Chandrasekhar 2012 (KSM-66), Auddy 2008 (Sensoril) |
| Thyroid interaction concern | Low — some theoretical concern at very high doses | Ashwagandha may affect thyroid hormones — consult GP if on thyroid medication |
| Recommended if... | High-demand work/study periods, daytime fatigue, stress resilience | Chronic stress, poor sleep, elevated cortisol, need for evening calming |
Some people use both adaptogens, typically taking Rhodiola rosea in the morning and ashwagandha in the evening. This is not a practice based on RCT evidence — it is an experiential pattern. If you are considering combining them, check for any medication interactions and discuss with your GP or pharmacist.
Where to Buy Rhodiola Rosea in Ireland
Rhodiola rosea is available in Ireland through multiple channels. Understanding what to look for helps you choose a quality product.
What to Check Before Buying
The key differences between Rhodiola rosea products are extract type (standardised vs whole root), potency, and manufacturer quality standards. GMP (Good Manufacturing Practice) certification is the minimum acceptable standard for any supplement manufactured for the Irish market.
| Brand / Product | Format | Dose | Standardised? | Available in Ireland |
|---|---|---|---|---|
| Swanson Rhodiola Rosea Root 400 mg | Whole-root capsules | 400 mg | No (full spectrum) | Yes — Probiotic.ie |
| Solgar Rhodiola Rosea Root Extract | Extract capsules | 60 mg extract | Yes (3% rosavins) | Selected health stores |
| Viridian Rhodiola Rosea | Extract capsules | 200 mg extract | Yes (3% rosavins) | Selected health stores |
| Holland & Barrett Rhodiola Rosea | Tablets | Varies | Check label | HB stores in Ireland |
Probiotic.ie stocks Swanson Rhodiola Rosea Root 400 mg — 100 capsules per pack, dispatched from our Dublin warehouse with next-day DPD delivery across Ireland. This is a whole-root powder product providing 400 mg of Rhodiola rosea root per capsule at GMP-certified standards.
All Swanson Rhodiola Rosea orders placed via Probiotic.ie are dispatched from our Dublin warehouse. Standard delivery is next business day via DPD tracked delivery across Ireland. No international shipping delays or customs duties apply. Probiotic.ie is an authorised Irish distributor for Swanson products and operates under FSAI food supplement guidelines.
Swanson Rhodiola Rosea Root 400 mg — Buy in Ireland
100 capsules · Full-spectrum root · Ships from Dublin · Next-day DPD delivery
Frequently Asked Questions
Rhodiola rosea is a traditional plant extract used to support the body's response to physical and mental stress. In published clinical trials, it has been studied for stress-related fatigue, burnout, and cognitive performance under demanding conditions. It is classified as a food supplement in Ireland — it is not a medicine and does not treat any medical condition. Consult your GP if you have a health concern.
Published clinical studies have examined Rhodiola rosea most extensively for stress-related fatigue and mental performance under pressure. A 2009 RCT by Olsson et al. (Phytomedicine) found significant reductions in burnout fatigue scores after 28 days with the SHR-5 standardised extract (p<0.05). A 2000 double-blind crossover study by Darbinyan et al. found improvements in mental performance in physicians during night duty. Evidence for mood support is suggestive but less definitive. All findings are from food supplement trials — not medicinal claims.
Published RCTs have used doses ranging from 170 mg to 576 mg per day of standardised Rhodiola rosea extract, typically standardised to 3% rosavins and 1% salidroside. Swanson Rhodiola Rosea Root 400 mg capsules provide 400 mg of whole-root powder per capsule — take one capsule once to twice daily with water, as directed on the label. Whole-root and standardised extract doses are not directly comparable. Always follow the product label and consult a GP if you are on any medication.
Some studies, including Shevtsov et al. 2003, observed improvements in acute cognitive performance within a single dose. For fatigue and mood outcomes, most RCTs suggest a minimum 4-week assessment period, with the Olsson et al. 2009 trial running for 28 days and the Lekomtseva et al. 2017 open-label trial showing continued improvement over 8 weeks. Individual response varies. If no benefit is noticed after 4–6 weeks of consistent use, review the dose and product type.
In published RCTs, Rhodiola rosea has been well tolerated. The most commonly reported side effects include mild dizziness, dry mouth, and occasional agitation, typically at higher doses and early in use. Some people find it mildly stimulating — taking it late in the day may affect sleep. It is not recommended during pregnancy or breastfeeding. If any adverse reaction occurs, discontinue use and consult a GP.
Rhodiola rosea active compounds are proposed to influence serotonin and monoamine pathways — the same systems targeted by antidepressant medications including SSRIs, SNRIs, tricyclics, and MAOIs. Combining Rhodiola rosea with these medications carries a theoretical risk of serotonin syndrome. This has not been established in clinical case data but represents a pharmacological caution. Do not combine Rhodiola rosea with any prescription antidepressant without first consulting your GP or psychiatrist.
Rhodiola rosea and ashwagandha (Withania somnifera) are both adaptogens with distinct profiles. Rhodiola rosea tends to be more stimulating and is best studied for acute stress-related fatigue and daytime cognitive performance. Ashwagandha is more calming and has stronger evidence for chronic stress, cortisol reduction, and sleep quality. Neither is universally better — the choice depends on what you are trying to support. Both are food supplements. Neither treats medical conditions.
Rosavins (rosavin, rosarin, rosin) are cinnamyl alcohol glycosides unique to Rhodiola rosea and are the primary standardisation markers used to verify genuine species identity. Salidroside (tyrosol glucoside) is present in multiple Rhodiola species and is considered a key contributor to adaptogenic activity. Research-backed extracts are standardised to 3% rosavins and 1% salidroside. Together, these compounds are proposed to modulate the HPA axis stress response and support monoamine neurotransmitter pathways, though full mechanisms in humans are not yet established.
A 2015 study by Cropley et al. (University of Surrey, published in Phytotherapy Research) found that Rhodiola rosea extract significantly reduced self-reported anxiety, stress, and anger scores over 14 days in a mildly anxious population. The study had no placebo control group. Clinical evidence for diagnosed anxiety disorders is absent — Rhodiola rosea is not a medicine and is not indicated for the treatment of any anxiety disorder. If you experience persistent or severe anxiety, consult your GP.
Rhodiola rosea is available in Ireland from pharmacies, health food stores, and online. Swanson Rhodiola Rosea Root 400 mg (100 capsules) is available from Probiotic.ie, an Irish supplement retailer based in Dublin. Orders are dispatched with next-day nationwide DPD delivery across Ireland. Probiotic.ie is an authorised Irish distributor for Swanson and operates under FSAI food supplement guidelines.
This guide is for educational purposes only and does not constitute medical advice. Swanson Rhodiola Rosea Root is a food supplement regulated under FSAI guidelines and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. If you have persistent or worsening symptoms — including fatigue, low mood, anxiety, or any other health concern — consult a GP or relevant specialist. Probiotic.ie is regulated under FSAI food supplement guidelines. Not a medicine.
- Anghelescu IG, Edwards D, Seifritz E, Kasper S. Stress management and the role of Rhodiola rosea: a review. International Journal of Psychiatry in Clinical Practice. 2018;22(4):242-252 — PubMed 29325481
- Shevtsov VA, Zholus BI, Shervarly VI, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003;10(2-3):95-105 — PubMed 12725561
- Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica. 2009;75(2):105-112 — PubMed 19016404
- Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue — A double blind cross-over study of a standardized extract SHR-5. Phytomedicine. 2000;7(5):365-371 — PubMed 11081987
- Lekomtseva Y, Zhukova I, Wacker A. Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial. Complementary Medicine Research. 2017;24(1):46-52 — PubMed 28219059
- Mao JJ, Xie SX, Zee J, et al. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394-399 — PubMed 25837277
- Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytotherapy Research. 2015;29(12):1934-1939 — PubMed 26502953